Nektar Therapeutics (LON:0UNL)
London · Delayed Price · Currency is GBP · Price in USD 56.82
-0.57 (-0.99%)
Dec 10, 2025, 4:56 PM BST
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
763.45K GBP
Profits / Employee
-1.47M GBP
Market Cap
898.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | 718 | -5 | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Nektar Therapeutics News
- 5 weeks ago - Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London - PRNewsWire
- 6 weeks ago - Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire
- 6 weeks ago - San Francisco is making a comeback. So are these stocks from the City by the Bay - CNBC
- 7 weeks ago - Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin Accepted for Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting - PRNewsWire
- 7 weeks ago - Nektar Therapeutics (NKTR) Rises on Takeover Speculation - GuruFocus
- 7 weeks ago - Nektar (NKTR) Shares Surge on M&A Rumor - GuruFocus
- 7 weeks ago - Nektar Therapeutics gains amid takeover speculation - Seeking Alpha
- 2 months ago - Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - The Motley Fool